Saturday 17 October 2026
Export EUDA’s income statement to Excel — free account
EUDA Health Holdings Limited
EUDA Real Estate Real Estate Services
EUDA Health Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 70.0% from fiscal 2024.
15.40
0.09
−0.58%
Follow EUDA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jul '22 | Dec '21 | Jul '21 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 86.63 | 589.95 | 0.00 | 0.00 | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(38.38) | (71.79) | (65.32) | (236.41) | (6,519.24) | 4,235.89 | 0.00 | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 26.78 | 3,133.52 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 26.78 | 0.00 | 0.00 | — |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(10.85) | (26.72) | (12.59) | (142.60) | (1,701.15) | 0.00 | 0.00 | — |
EV/FCF |
(10.74) | (26.72) | (12.59) | (142.60) | (1,701.15) | 0.00 | 0.00 | — |
Quick Ratio |
0.12 | 0.10 | 0.05 | 0.03 | 0.85 | 0.59 | 0.58 | — |
Current Ratio |
0.18 | 0.18 | 0.08 | 0.86 | 0.86 | 0.60 | 0.60 | — |
Net Debt/EBITDA |
(0.80) | (0.04) | (0.15) | 0.04 | (0.57) | (0.18) | (0.28) | — |
Debt/Assets |
126.23% | 58.30% | 60.13% | 0.86% | 15.13% | 4.64% | 5.78% | 0.00% |
Debt/Equity |
(0.51) | (0.38) | (0.11) | (0.06) | (1.10) | 0.62 | 0.89 | — |
Asset Turnover |
4.00 | 2.67 | 0.28 | 0.15 | 0.59 | 1.32 | 2.64 | — |
Operating CF/Net income |
0.88 | 0.13 | 0.29 | 0.06 | 0.06 | 0.51 | 0.51 | — |
Capex/Depreciation |
(0.54) | (2.74) | 0.00 | (0.15) | 0.00 | (0.01) | 0.00 | — |
Interest Coverage |
(10.84) | (386.08) | (170.74) | (130.27) | — | (9.66) | (1.20) | — |
| 81.08% | 305.49% | 182.72% | 708.19% | 1,704.16% | 154.25% | 0.00% | — | |
| (162.42%) | (1,020.99%) | (74.53%) | (97.09%) | (148.00%) | 10.81% | 21.62% | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (98.27%) | 0.00% | — |
Return on Tangible Assets |
59.52% | 466.67% | 125.69% | 612.46% | 626.79% | (29.76%) | (30.86%) | — |
Average Days of Receivables |
17.89 | 15.50 | 23.56 | 18.96 | 890.65 | 141.62 | 141.52 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.46% | 0.17% | 1.23% | 1.23% | — |
Selling, General and Administrative Expense of Revenue |
79.66% | 83.31% | 129.59% | 317.46% | 92.03% | 50.67% | 50.67% | — |
Intangible Assets out of Total Assets |
0.09 | 0.20 | 0.00 | 0.00 | 0.00 | 0.16 | 0.16 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
(0.10) | (0.08) | (0.21) | (0.01) | 0.04 | 0.00 | 0.00 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 7.49 | 0.00 | 0.00 | — |
Earnings Yield |
(5.95%) | (3.07%) | (9.05%) | 1.15% | 0.17% | (0.01%) | (0.01%) | — |
Free Cash Flow Yield |
(9.68%) | (3.74%) | (8.01%) | (0.70%) | (0.06%) | 0.00% | 0.00% | — |
Revenue per Share |
3.65 | 2.47 | 3.24 | 6.26 | 0.82 | 22.79 | 1.14 | — |
Operating CF per Share |
(1.30) | (1.25) | (2.55) | (2.54) | (0.13) | 0.96 | 0.05 | — |
Capex per Share |
(0.06) | (0.07) | 0.00 | (0.03) | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(1.35) | (1.33) | (2.55) | (2.57) | (0.13) | 0.96 | 0.05 | — |
Cash per Share |
0.18 | 0.15 | 0.17 | 1.16 | 0.07 | 0.41 | 0.02 | — |
Shareholders Equity per Share |
(2.28) | (1.58) | (6.53) | (5.83) | (0.29) | 1.30 | 0.06 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(2.28) | (1.58) | (6.53) | (5.83) | (0.29) | 1.30 | 0.06 | — |
Free Cash Flow |
(2.53) | (2.15) | (2.92) | (1.54) | (1.53) | 0.44 | 0.44 | — |
Working Capital |
(4.80) | (3.38) | (7.99) | (4.09) | (4.09) | (2.96) | (2.96) | — |
Capital Expenditures |
(0.10) | (0.12) | — | (0.02) | (0.02) | 0.00 | 0.00 | — |
Net Current Asset Value |
(4.94) | (3.51) | (8.07) | (4.11) | (4.11) | (3.05) | (3.05) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
1.42 | 0.48 | 0.73 | 3.84 | 1.99 | 3.47 | 1.59 | — |
Cash ROIC |
144.17% | 159.95% | 44.86% | 59.68% | (133.63%) | 38.06% | 37.82% | — |
Accounts Receivable Turnover |
27.04 | 19.59 | 17.05 | 0.31 | 0.70 | 2.58 | 0.00 | — |
Accounts Payable Turnover |
5.53 | 11.15 | 3.50 | 1.77 | 2.91 | 2.23 | 0.00 | — |
Inventory Turnover |
58.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
76.69 | 65.31 | 0.17 | 206.25 | 92.03 | 163.32 | 163.32 | — |
Days of Inventory on Hand |
0.27 | 14.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
0.25 | 0.20 | 0.22 | 12.10 | 14.05 | 4.09 | — | — |
Average Payables |
0.69 | 0.29 | 0.82 | 1.64 | 2.23 | 2.82 | — | — |
Average Inventory |
0.07 | — | — | — | — | — | — | — |
Average Assets |
1.71 | 1.50 | 13.47 | 25.63 | 16.81 | 8.00 | 4.00 | — |
Average Common Equity |
(3.42) | (5.03) | (5.49) | (3.51) | (1.46) | 0.56 | — | — |
Columns are period end dates · fundamentals updated 1 Oct 2026